Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis on ALT stock.

Altimmune has shared an update on the metabolic dysfunction-associated steatohepatitis (MASH) study that sank its stock in June. The 48-week readout linked the top dose of the GLP-1/glucagon dual ...

An Eldoret-bound bus operated by Mash Poa was set ablaze by boda boda riders after it was involved in an accident that killed ...

ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fifty percent of patients treated with 6 mg survodutide ...

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...

US biotech Altimmune (Nasdaq: ALT) said its experimental MASH drug pemvidutide delivered sustained improvements in key ...

About Unlike straight bourbon or rye, the sour mash designation refers to the traditional method of using a portion of a ...

The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...

23:58, Fri, Feb 7, 2025 Updated: 00:39, Sat, Feb 8, 2025 Spanning 11 seasons, M*A*S*H was a beloved comedy-drama that chronicled the highs and lows of the staff at the United States Army Mobile Army ...

Fox will celebrate MASH: The Comedy That Changed Television in a new two-hour special set to air Monday, January 1 at 8 pm on the network. A definitive look at the 14-time Emmy-winning television ...

Cathy Chaplin is a former senior editor at Eater LA, a James Beard Award–nominated journalist, and the author of Food Lovers’ Guide to Los Angeles. Chef Diego Argoti’s acclaimed Poltergeist residency ...